Introduction {#sec1-1}
============

Economic growth of a country depends on added-value production as much or more than manpower and capital. The former when transposed to science or specifically, to medicine is congruent with research output. The impact of this output somewhat parallels the entire base, but is significantly driven by top publications.

Adoption of appropriate indicators of activity of scientific publication is required for appropriate assignment of national resources ([@ref1]). In this connection, the number of publications with "top" citations rather than the overall number of citations is a better or the best indicator of contribution to science with respect to scientific institutions or countries ([@ref2]). Currently, one-fifth of the 1 million scientific papers are coauthored by researchers collaborating internationally ([@ref3]). Multiauthored international publications have substantially increased in recent years, such that less than one-fifth of scientific publications have a single author, \>600 papers are published with \>100 authors ([@ref4]). Though one may agree that best results in science come from international collaboration ([@ref3],[@ref5]), the advantage of this practice favors the restricted growth potential of advanced economies, whereas the growth potential of domestic publications in emerging economies is still great. Hence, for communities emerging in medical research, increasing proportion of internationally "collaborative" papers and their acquired citations is a major confounder compared with research "genuinely" originating from native institutions. In Turkey, I have documented that an overwhelming proportion of Turkey's contribution to medicine belonged to internationally "collaborative" papers, which does not reflect a sustainable capacity ([@ref6]).

This article aims 1) to identify prominent publications (on the basis of citations as an indicator of contribution to cardiovascular medicine) in the past 25 years derived from native academic institutions and hospitals and their primary authors and 2) to evaluate the trend of such activity in Turkey in the period under study.

Methods {#sec1-2}
=======

Data from Thomson Reuters Web of Science (Core Collection) served to obtain current citations using "Turkey or Türkiye" as address. Publications in clinical medicine and cardiovascular medicine were targeted. When sorted by the highest to lowest citations, articles or reviews cited ≥50 were selected. "Genuine" contributions were defined when all first three authors of the paper worked in a Turkish university or hospital. All remaining "collaborative" articles were excluded. Following criteria were also need to be met to qualify: either the primary author had to be a cardiologist or the main topic was required to be on the field and publication was to be in a periodical confined to cardiovascular medicine. In total, 147 papers were identified.

In papers with coauthors from multiple institutions, the first author and his/her institution were credited and listed. With the purpose of precluding omission of some researchers in the address "Turkey," some 50 primary authors known to me from a previous work ([@ref7]) were also individually searched. For those authors who produced highly-cited papers (denoting a wider meaning than the same term used in the Web of Science) in two different institutions, citations received were assigned to the two institutions.

The closing index date in the current study for data retrieved from the Web of Science was late July, 2017. These data exclude intrinsically eligible citations to references incorrectly or ina-dequately provided and to periodicals not covered by the Web of Science. These excluded citations may be estimated to form a share of 5%--10% of the Web of Science citations.

Estimates of the expected distribution of "highly-cited" papers were based on the number of papers observed in 2005 and on the 10th percentile data provided by the Web of Science.

In assessing the rate of generation of such papers, the elapsed period from the index date of the median (25th and 75th percentiles) publication year was used and was compared with that of a work that preceded this study by 2 years ([@ref7]).

Results {#sec1-3}
=======

The number of "genuine" papers in cardiovascular medicine published in the previous quarter century that received ≥50 citations was 147. Overall citations received by these papers were 11,492. [Table 1](#T1){ref-type="table"} comprises source information of these "genuine" articles.

###### 

147 articles from Turkey with highest "genuine" contribution to cardiovascular medicine: information on field, institution and reference

  Cites   Authors                                  Field        Inst.      Topic                                         Journal                           Year & reference
  ------- ---------------------------------------- ------------ ---------- --------------------------------------------- --------------------------------- --------------------
  392     Abacı A, Oğuzhan A, Kahraman S &         Card         Erc        Coronary collaterals                          Circulation                       1999; 99: 2239-42
  233     Kalay N, Başar E, Özdoğru İ &            Card-Onc     Erc        Carvedilol-cardiomyopathy                     J Am Coll Cardiol                 2006; 48: 2258-62
  223     Onat A, Ceyhan K, Başar Ö &              Card         CPş        Metbolic syndrome                             Atherosclerosis                   2002; 165: 285-92
  188     Onat A                                   Card         CPş        Cardiovascular disease                        Atherosclerosis                   2001; 156: 1-10
  176     Tokgözoğlu SL, BaturMK, Topcuog MA &     Card         HT         Stroke localization                           Stroke                            1999: 30: 1307-1
  174     Tarkun İ, Çetinarslan B, Cantürk Z &     End-Card     Kocaeli    PCOS: inflammation                            J Clin Endo Metab                 2004; 89: 5592-6
  158     Onat A, Şurdum-Avcı G, Barlan MM &       Card         CPş        Visceral adiposity                            Int J Obes                        2004; 28: 1018-25
  150     Eren M, Görgülü Ş, Uslu N &              Card         Ersek      Aortic stiffness in HT, DM                    Heart                             2004; 90: 37-43
  150     Aytemir K, Ozer N, Atalar E &            Card         HT         P-wave dispersion                             PACE                              2000; 23: 1109-12
  145     Kosecik M, Erel O, Sevinc E. et al.      Ped. C       Harran     Children & passive smoking                    Int J Cardiology                  2005; 100: 61-4
  133     Onat A, Uyarel H, Hergenç G &            Card         CPş        Üric acid & metab synd                        Am J Hypertens                    2006; 19: 1055-62
  130     Sezgin AT, Sığırcı A, Barutçu İ &        Card         Başkt      Slow coronary flow                            Coron Artery Dis                  2003; 14; 155-61
  122     Tüzün H, Beşirli K, Sayın A &            CVS          CPş        Aneurysm in Behçet's                          Surgery                           1997; 121: 150-6
  118     Eroğlu S, Sade LE, Yıldırır A &          Card         Ht/Bk      Epicardial fat-CAD                            Nutr Met Cardiov Dis              2009; 19: 211-7:
  115     Yaralı H, Yildirir A, Aybar F &          Gyn-C        HT         Policystic ovary syndr.                       Fertil Steril                     2001: 76: 511-6
  114     Çelik T, İyisoy A, Kursaklıoğlu H &      Card         GATA       Effect on oxidat. stress                      J Hypertension                    2006; 24: 591-6:
  113     Yazici S, Yazici M, Erer B. et al.       PhM-C        Düzce      Platelet indices in rheumatoid arthr.         Platelets                         2010; 21: 122-25
  113     Özkan M, Kaymaz C, Kırma C &             Card         Koşuy      Valvular thrombosis                           J Am Coll Cardiol                 2000; 35: 1881-9
  109     Aras D, Tüfekçioğ, Kumral E &            Card         TYİH       Ventric. noncompaction                        J Card Fail                       2006; 12: 726-33
  109     Güvener M, Paşaoğlu İ, Demircin M        CVS          HT         Postop hyperglycemia                          Endocrine J                       2002; 49: 531-7
  109     Taşdemir O, Vural KM, Karagöz H &        CVS          TYİH       Cardiac surgery without bypass                J Thor Cardiov Surg               1998; 116: 68-73
  108     Özcan EE, Güneri S, Akdeniz B &          Card         9Eyl       Radiocontrast nephropathy                     Am Heart J                        2007; 154: 539-44
  103     Tavil Y, Şen N, Yazıcı HU. et al.        Card         Gazi       Mean platelet vol. MetS.CAD                   Thromb Res                        2007; 120; 245-50
  103     Okutan H, Ozçelik N, Yilmaz HR. et al.   CVS          Demirel    Caffeic acid & lipid peroxidation             Clin Biochem                      2005; 38: 191-96
  102     Erdoğan D, Güllü H, Yıldırım E &         Card         Demir      Low bilirubin; carotid IMT                    Atherosclerosis                   2006; 184: 431-7
  101     Onat A, Uyarel H, Hergenç G &            Card         CPş        Abdominal obesity                             Atherosclerosis                   2007; 191: 182-90
  101     Demirkılıç U, Kuralay E, Yenicesu M &    CVS          GATA       Postop renal failure                          J Cardiac Surg                    2004; 19: 17-20
  95      Farsak B, Yıldırır A, Akyön Y &          CVS          HT         Bacterial DNA ın plaques                      J Clin Microbiol                  2000; 38: 4408-11
  93      Özaydın M, Varol E, Aslan SM &           Card         Demirel    Statin- atr.fibrillation                      Am J Cardiol                      2006; 97: 1490-3
  93      Özer N, Yavuz B, Can İ &                 Card         HT         Doppler; T-wave dispersion                    J Am Soc Echocard                 2005; 18: 945-8
  92      Durdu S, Akar AR, Arat M. et al.         CVS          Ank U      Thrombangiit. oblit. Cell transplant.         J Vasc Surg                       2006; 44: 732-9
  91      Erdoğan D, Güllü H, Çalışkan M &         Card         Demir      Uric acid; endothel functn                    Int J Clin Pract                  2005; 59: 1276-82
  90      Şenaran H, İleri M, Altınbaş A&          Hem-Card     Fatih      Platelet vol.-CAD                             Clin Cardiol                      2001; 24405-8
  89      Akpek M, Kaya MG, Lam YY &               Card         Erciye     Neut/Lympho-coron. flow                       Am J Cardiol                      2012; 110: 621-7
  89      Bilge AK, Ozben B, Demircan S. et al.    Card         Çapa       Depression & defibrillator                    PACE                              2006; 29: 619-26
  86      Uyarel H, Ergelen M, Çiçek G, &          Card         B'esir     Redcell distr width, prognosis                Coron Artery Dis                  2011; 22: 138-44
  86      Ak K, Isbir CS, Tetik S. et al.          CVS.         Marmara    Algorithm blood product use after CABG:       J Cardiac Surg                    2009: 24404-10
  86      Dursunoğlu D, Evrengül H, Polat B, &     Card         Pamukk.    Lp(a) and lipids in rheumatoid arthritis      Rheumatol Int                     2005; 25: 241-5
  86      Kayıkçıoğl M, Tumuklu M, Özkahya M &     Card-Neph    Ege        Salt restrict.-End-st. renal dis.             Nephrol Dial Transpl              2009; 24: 956-62
  84      Onat A, Hergenç G, Sansoy V &            Card         CPş        ApoC-III & coronary risk                      Atherosclerosis                   2003; 168: 81-9
  84      Onat A, Avcı GŞ, Şenocak M &             Card         CPş        Lipids in Turkey                              J Epid Commun Hlth                1992; 46: 470-6
  82      Zorlu A, Bektaşoğlu G, Güven FM &        Card.        Cumh.      Red cell distrib.width. pulm.embolism         Am J Cardiol                      2012; 109: 128-34
  82      Özkan Y, Özkan E, Şimşek B &             Ecz-Card     Gazi       Homocystein and cysteine CHD RF               Int J Cardiol                     2002; 82: 269-77
  82      Hür E, Usta M, Toz H. et al.             Nphr-Card    Ege        Cardiovsc parameters in hemodialysis          Am J Kidneu Dis                   2013; 61-957-65
  81      Kiziltepe U, Turan NN, Han U. et al.     CVS          AnkAcil    Resveratrol, spinal cord ischemia             J Vasc Surg                       2004; 40:138-45
  80      Sönmez B, Demirsoy E, Yağan N &          CVS          Nighting   Ablation: atrio-esophageal fistula            Ann Thorac Surg                   2003; 76:81-3
  79      Özaydın M, Peker O, Erdoğan D &          Card         Demir      Postop. Atrial fibrill. Rx                    Eur Heart J                       2008; 29:625-31
  77      Kılıçkap S, Barista I, Akgul E. et al.   Onc.Card     HT         cTnT. anthracycline cardiotoxicity            Ann Oncol                         2005; 16:798-804
  76      Kucur M, Isman FK, Karadag B. et al.     Biochem      CPş        Serum YKL-40 levels in CAD                    Coron Artery Dis                  2007; 18:391-6
  75      Dede DŞ, Yavuz B, Yavuz BB &             Card         HT         Alzheimer endothel. function                  J Am Geriatr Soc                  2007; 55:1613-7
  74      Onat A, Hergenç G, Yüksel H &            Card         CPş        Neck circ. Sleep apnea                        Clin Nutr                         2009; 28:46-
  74      Altun A, Uğur-Altun B.                   Card-Endo.   Trakya     Melatonin: therapeutic utilization            Int J Clinl Pract                 2007; 61:835-45
  74      Erdoğan D, Yıldırım E, Çiftçi Ö &        Card         Demir      PreHT; cor. microvascular                     Circulation                       2007; 115:593-9
  73      Diker E, Aydoğdu S, Özdemir M &          Card         TYİH       Atrial fibrillation                           Am J Cardiol                      1996; 77:96-8
  72      Kaya MG, Yarlıoğlueş M, Günbakmaz Ö &    Card         Erciy      Platel. activ; hypertension                   Atherosclerosis                   2010; 209:278-82
  72      Sezer M, Oflaz H, Gören T. et al.        Card         Çapa       Intracoron.streptokinase p. primary PCI       N Engl J Med                      2007; 356:1823-34
  71      Kaya MG, Özkan Mt, Günebakmaz O&         Card         Erciy      Nebivolol; anthrac.cardiomyopathy             Int J Cardiol                     2013; 167:2306-10
  71      Demirkol S, Balta Ş, Ünlü M &            Card         GATA       Mean platelet vol. Syndr. X                   Clinics                           2012; 67:1019-22
  71      Doğancı S, Demirkılıç U                  CVS          GATA       Laser &fibre Rx: saphen.varices               Eur J Vasc Surg                   2010; 40:254-9
  70      Sade LE, Eroğlu S, Bozbaş H &            Card         HT         Epicardial fat-coron.reserve                  Atherosclerosis                   2009; 204:580-5
  70      Yılmaz MI, Sönmez A, Çağlar K &          Card         GATA       Antihyp. Rx- adiponectin                      Nephrology                        2007; 12:147-53
  67      Güray U, Erbay AR, Güray Y &             Card         TYIH       Adhesion molecules                            Int J Cardiol                     2004; 96:235-40
  67      Tükek T, Akkaya V, Demirel S. et al.     Card.        Çapa       Valsalva. P-dispersion in parox. AFib         Am J Cardiol                      2000; 85:896-9
  65      Turhan H, Saydam GS, Erbay AR, &         Card         İnönü-     Adhesion mol.-slow cor flow                   Int J Cardiol                     2006; 108:2024-30
  65      Pekdemir H, Cin VG, Ciçek D. et al.      Card.        Mersin     Slow coronary flow.FFR & IVUS                 Acta Cardiol                      2004; 59:127-33
  65      Kayıkçıoğ M, Payzın S, Yavuzgil O &      Card         Ege        Statin in syndrome X                          Eur Heart J                       2003; 24:1999-2005
  65      Onat A, Can G, Kaya H &                  Card         CPş        Atherogenic index, vasc. events               J Clin Lipidol                    2010; 4:89-98
  64      Acar G, Akcay A, Sokmen A. et al.        Card         K.'maraş   Diast. function in diabetes                   J Am Soc Echocard                 2009; 22:732-8
  64      Karabulut H, Toraman F, Evrenkaya S &    CVS          Acıbd      Clopidogrel in CABG                           Eur J Cardiothor Surg             2004; 25:419-23
  64      Çamsarı A, Pekdemir H, Çiçek D. et al.   Card.        Mersin     Endothelin-1, NO & slow coron. flow           Circ J                            2003; 67:1022-8
  64      Cin VG, Pekdemir H, Camsar A. et al.     Card.        Mersin     Coron. intimal thickening in slow cor. flow   Jap Heart J                       2003; 44:907-19
  64      Bahar I, Akgul A, Ozatik MA. et al.      CVS          TYİH       Renal failure. open heart surgery             Perfusion-Uk                      2005; 20:317-22
  63      Erbil Y, Ademoğlu E, Ozbey N &           Surg         Çapa       CV risk in Cushing - surgery                  World J Surg                      2006;30:1665-7
  62      Özkan M, Gündüz S, Biteker M &           Card         Koşuy      Thrombolysis.Valve thrombosis                 JACC CV İmag                      2013; 6:206-16
  62      Onat A, Özhan H, Esen AM &               Card         CPş        Smoking -- diabetes/MetS                      Atherosclerosis                   2007; 193:330-8
  62      Toraman F, Karabulut EH, Alhan HC &      CVS          Acb/Ersk   Post CABG atr fibrillation                    Ann Thor Surg                     2001; 72:1256-61
  61      Çalışkan M, Erdoğan D, Güllü H &         Card         Demir      LV function-Ankyl.spodylitis                  Atherosclerosis                   2008; 195:306-12
  61      Özaydın M, Doğan A, Varol E, &           Card         Demirel    Postop. atr.fibrillation                      Cardiology                        2007; 107:117-21
  61      Mercanoğlu F, Oflaz H, Öz O, &           Card.        Çapa       Endothelial dysfunction & perlodontitis       J Periodontol                     2004; 75:1694-700
  61      Yıldırır A, Kabakçı G, Akgül E &         Card         Ht/Bk      Menses--heart rate variab.                    Ann Noninv Electroc.              2002; 7:60-3
  61      Özer N, Aytemir K, Atalar E &            Card         HT         P-wave. disperson                             PACE                              2000; 23:1859-62
  61      Saydam N, Kirb A, Demir O &              CVS          ½9Eyl      Cancer tissue                                 Cancer Letters                    1997; 119:13-9
  60      Özhan H, Erden I, Ordu S. et al.         Card.        Düzce.     Atorvastatin. contrast-induc. nephropathy     Angiology                         2010; 61:711-4
  59      Yavuz B, Ertuğrul DT, Çil H &            Card         HT         Vitamin D Rosuvastatin                        Cardiov DrugsTher                 2009; 23:295-9
  53      Vural KM, Şener E, Taşdemir O &          CVS          TYİH       Valsalva sinus aneurysm                       Eur J Cardiothor Surg             2001; 20: 71-6
  52      Yılmaz MB, Cihan G, Güray Y &            Card         TYİH       Platelet vol.-ACS                             J Thromb Thrombolys               2008; 26: 49-54
  52      Arslan U, Türkoğlu S, Balcıoğlu S, &     Card.        Gazi U.    Nonalcoholic fatty liver & CAD                Coron Artery Dis                  2007; 18: 433-6
  52      Iltumur K, Yavavli A, Apak I. et al.     Card.        Dicle U.   N-T natriuretic peptide in stroke             Am Heart J                        2006; 151: 1115-22
  52      Ağırbaşlı M                              Card.        Marmara    Plasminogen-activ. Inhib.--1 in vasc.dis.     Int J Clinl Pract                 2005; 59: 102-6
  52      Gürgün C, Ercan E, Ceyhan C &            Card         Ege        CV involv. in Behçet's                        Jap Heart J                       2002; 43: 389-98
  52      Gölbaşı Z, Uçar O, Keleş T &             Card         Nüm        CRP; rheum valve dis.                         Eur J Heart Fail                  2002; 4: 593-5
  52      Özkutlu S, Ayabakan C, Çeliker A&        Ped C        HT         Myocard noncompaction                         J Am Soc Echocard                 2002; 15: 1523-8
  52      Kaplan M, Demirtaş M, Çimen S&           CVS          Ersek      Cardiac hydatid cysts                         Ann Thor Surg 2001; 71: 1587-90   
  52      Uysal S, Kalaycı AG, Baysal K. et al.    Ped C        19 May..   Cardiac function: rickets                     Ped Cardiol                       1999; 20: 283-6
  51      Tümüklü MM, Etika İ, Kısacık B &         Card         GOP Tok    Obesity, LV structure                         Echocardiography                  2007; 24: 802-9
  51      Tanrıverdi H, Evrengul H, Kuru O &       Card.        Pamukk     Smoking oxidative stress coron. flow          Circ J                            2006; 70: 593-9
  51      Yılmaz AT, Arslan M, Demirkılıç U &      CVS          GATA       Postop GI complications                       Eur J Cardiothor Surg             1996; 10: 763-7
  50      Balta Ş, Demirkol S, Çelik T. et al.     Derm-Card    GATA       High endocan. psoriasis                       Angiology                         2013; 64: 627-32
  50      Kalay N, Doğdu O, Koç F. et al.          Card         Erciyes    Blood cell counts. Coron progression          Angiology                         2012; 63: 213-7
  50      Kaya MG, Uyarel H, Akpek M. et al.       Card         Erciyes    Uric acid. ST-MI. PCI                         Am J Cardiol 2012; 109: 486-91    
  50      Onat A                                   Card         CPş        MetS natural history                          Exp Opin Pharmacoth               2011; 12: 1887-
  50      Yılmaz MB, Yalta K, Yontar C. et al.     Card.        Cumhur.    Levosimendan in acute heart failure:          Cardiov Drugs Ther                2007; 21: 431-5
  50      Erdoğan HB, Kayalar N, Ardal H &         CVS          Koşu       Pacemaker P aortic valve replac.              J Card Surg                       2006; 21: 211-5
  50      Özal E, Kuralay E, Yıldırım V. et al.    CVS          GATA       Methylene blue for vasoplegic                 Ann Thorac Surg                   2005; 79: 1615-9
  50      Yılmaz MB, Bıyıkoğlu SF, Akın Y &        Card         TYİH       Obesity-coron. collaterals                    Int J Obes                        2003; 27: 1541-5

11492; 147\*78

31+63improved 18.9%, annually 9%.

AO 14\*98.6=1387 cites=12.1% improved 17%, annually 8.2%

Temporal distribution of the number of these publications is graphically presented in [Fig. 1](#F1){ref-type="fig"}. The graph reveals that the publication of the papers had a median year (25th and 75th percentiles) of 2005 (from 2002 to late 2007). Expressed otherwise, the exposure period consisted of a median o 12 (IQR 9.5--15) years. Only 33 papers (23%) have been published after 2007, i.e., in the latest 9 years.

![Distribution of the 147 pubications in cardiovascular medicine achieving ≥50 citations by published year. Just over half of the papers had been published in the period from 2002 to 2007. A more rapid than anticipated decline is observed after 2006. The estimated average expectation of number of articles in the 8 years preceding the index date is diagrammatically represented, based on data form the Web of Science where citations to an item 3--4 years after publication are half those to an item 8 years after publication](AJC-18-417-g001){#F1}

Papers in the three fields of cardiovascular medicine were distributed as follows: an overwhelming proportion, namely, 105 papers belonged to cardiology, 27 belonged to cardiovascular surgery, and 5 belonged to pediatric cardiology. In 20 shared articles, cardiologists collaborated with specialists in endocrinology, nephrology, biochemistry, dermatology, internal medicine gynecology, oncology, hematology, public health, physical medicine, and pharmacology.

Front-running institutions {#sec2-1}
--------------------------

Only 33 medical institutions produced the 147 papers. Hacettepe Med Fac and Cerrahpaşa Med Fac were leading, each with 16 papers, and Gülhane Military Academy, Kartal Koşuyolu Res Hospital, Turkey's Yüksek İhtisas Hospital, Erciyes U. and S. Demirel U. Med. faculties were runners-up with 7--10 papers ([Table 2](#T2){ref-type="table"}). Istanbul U. Istanbul, Ege U. and Inönü U. Med. faculties followed. Further, 23 institutions generated the remaining 45 publications. Eight hospitals not affiliated with academia contributed to 26 publications (18% of the total).

###### 

Thirty-eight source institutions of the "highly" cited papers

  ----- ----------------------------------------------- ----- -----------------------------------
  16    Hacettepe U. Med Fac., Ankara                   2     Dokuz Eylül U. Med Fac., Izmir
  16    İ.U. Cerrahpaşa Med. Fac., İstanbul             2     19 Mayıs U. Med Fac.
  11    Gülhane Military Medical Academy, Ank.          2     Marmara U. Med Fac.
  10    Kartal Koşuyolu Res. Hospital, Istanbul         2     Düzce U. Med Fac.
  8     Turkey's Yİ Hosp., Ankara                       1,5   Acıbadem Hosp., Istanbul
  8     Sül. Demirel U. Med Fac., Isparta               1     Trakya U. Med Fac.
  8     Erciyes U. Med Fac., Kayseri                    1     Balıkesir U. Med Fac.
  7,5   I.U. Istanbul Med. Fac.                         1     Fatih U. Med Fac., Ankara
  7     Ege U. Med Fac., Izmir                          1     Flor. Nightingale Hosp., Istanbul
  4,5   İnönü U. Med Fac., Malatya                      1     Dicle U. Med Fac.
  4     Pamukkale U Med Fac., Denizli                   1     Acil &Traumat. Hosp, Ankara
  4     Başkent U. Med Fac., Ankara                     1     Nümune Hosp., Ankara
  3     Harran U. Med Fac.                              1     Vakıf Gureba Hosp., İst.
  3     Mersin U. Med Fac.                              1     Mustafa Kemal U, Hatay
  3     Ankara U. Med Fac.                              1     Atakalp Hosp., İzmir
  3     Kocaeli U. Med Fac.                             1     Haydarpaşa Nümune Hosp, Ist.
  2,5   S. Ersek Center for Cardiovasc. Surgery, Ist.   1     Gaziosmanpş. U., Tokat
  3     Gazi U. Med Fac., Ankara                        1     Güven Hosp., Ankara
  2     Cumhuriyet U. Med Fac.                          1     Sütçü İmam U., Kahr'maraş
                                                        147   
  ----- ----------------------------------------------- ----- -----------------------------------

Eighteen primary authors of multiple publications are listed in [Table 3](#T3){ref-type="table"}, together with the total number of their citations, affiliated institutions, and temporal period of their contributions. Collectively, they produced 38.0% of the articles and citations received.

###### 

List of 18 primary authors with multiple publications, their total citations, institutions and periods of contribution

  Pap   Cites   Investigator      Institution   Period     Pap   Cites   Investigator        Institution   Period
  ----- ------- ----------------- ------------- ---------- ----- ------- ------------------- ------------- ----------
  14    1387    Altan Onat        Cerrahpaşa    1992-'14   3     159     Şevket Balta        GATA          2013-'14
  2     283     Nihat Kalay       Erciyes Ü     2006-'12   3     152     M Birhan Yılmaz     TYİH          2003-'08
  3     263     Doğan Erdoğan     S Demirel     2006-'08   2     154     Necla Özer          Hacettepe     2000-'05
  3     233     Mehmet Özaydın    S Demirel     2006-'08   2     137     Dursun Dursunoğlu   Pamukkale     2005
  3     231     Mehmet Özkan      Koşuyolu      1992-'13   2     126     L. Elif Sade        Hacettepe     2008-'09
  2     227     İlknur Tarkun     Kocaeli U.    2004-'05   2     126     Meral Kayıkçıoğlu   Ege U.        2003-'09
  2     205     Lale Tokgözoğlu   Hacettepe     1999       2     108     Burak Pamukçu       Çapa          2005-'06
  3     193     Mehmet G. Kaya    Erciyes Ü     2002-'13   2     107     Yelda Başaran       Koşuyolu      1996-'11
  3     180     Hakan Turhan      İnönü         2004-'06   2     100     Mehmet Kaplan       S. Ersek      2001-'02
                                                           55    4371    38.0% of total                    

The articles were published with a predilection in following periodicals: nearly two-fifths, i.e., 55 in the following nine journals: Atherosclerosis (10 papers); Am J Cardiol (9 papers); Ann Thorac Surg (8 papers); Int J Cardiol (7 papers); Coron Artery Dis (5 papers); and Eur J Cardiothor Surg, Heart, Am Heart J, and Angiology (each 4 papers).

Discussion {#sec1-4}
==========

What is the impact and its trend of "genuine" contribution of Turkey's medical institutions to global knowledge on cardiovascular medicine in the past quarter century based on data retrieved from the Web of Science? This was assessed in this article. Publications representing internationally "collaborative" papers were excluded because it was recently shown that such papers, forming over two-thirds of our relatively highly-cited publications, diluted the actual performance capacity of the country ([@ref6]).

The vast review by Adams ([@ref5]) of publications from the Web of Science disclosed that domestic publications had flattened in the U.S. and Western Europe, and publication increases were due to international collaboration. In the U.S., papers with at least one author from another country in 2011 were found to be cited 1.36-fold more often than purely domestic research ([@ref5]). Of note is that, while the proportion of domestic papers in the total papers have decreased in the past two decades to 30%--50% in Switzerland and the U.K., this has been stable at approximately 75% in emerging countries, such as China, South Korea, and Brazil ([@ref5]).

Following main findings were elicited. A total of 147 papers achieved this level of citation, which indicates roughly the top 12% of global papers in cardiovascular medicine. The median exposure time was 12 years, longer than the 10.4 years determined 2 years previously. Only 33 articles published after 2007 attained this level of citations. Thirty-three institutions generated this research. Non-academic hospitals contributed to 18% of the papers. Younger researchers, though relatively few in number, have notably participated in generating these articles.

General agreement exists that the number of relatively highly-cited papers are the best indicator of contribution to science ([@ref1], [@ref2]), which is supported by the adoption of papers with \> 10% citations as a criterion in the Leiden University Ranking ([@ref7]).

Overall performance compared with that 2 years previously {#sec2-2}
---------------------------------------------------------

Data provided by Essential Science Indicators ([@ref9]) inform us that in clinical medicine (which excludes biochemistry, molecular biology, and neuroscience from overall medicine), following mean annual data were recorded in the Web of Science in the 10-year period from 2007 to 2016: 245.000 papers and 1.41 million citations in the world and 7400 papers and 19,150 citations in Turkey. It may be inferred that papers cited herein represent 2% of those generated in Turkey in cardiovascular medicine and that citations received by these papers make up (6% of those in clinical medicine) approximately one-third of those received by genuine papers in cardiovascular medicine in Turkey.

The selection of 50 citations as a threshold in this evaluation is highly comparable with that of 40 citations considered 2 years previously ([@ref8]) because overall citations covered by the Web of Science increased by just over 24% in that short period.

The median exposure period is an important parameter to be taken into account because cumulative citations are strongly time-dependent. The 6 years from 2002 through 2007 comprised slightly more than one-half of the total publications, namely 86 publications, revealing that an annual mean of 14 papers were generated of this quality in cardiovascular medicine in Turkey. In view of the availability of 80 medical faculties plus the research hospitals of the Health Ministry, this performance falls short of what might be anticipated.

Estimating that the average number of top 12% of papers in cardiovascular medicine in the past decade is approximately 2500 per year, the generation of a mean of 10--12 papers per year in Turkey (in the first decade of this century) reflects an approximately global share of 4--5 per mille. In view of a declining trend thereafter, the performance is unsatisfactory with respect to the potential of Turkey.

Cardiovascular surgery and particularly, pediatric cardiolo-gy, have not kept up with the expectations. Papers in these two broad fields generated only 21% of high-quality papers in this period. Separate reasons for this deserve to be detected.

Institutions and researchers {#sec2-3}
----------------------------

It is to be noted that broadly, only one of the three medical faculties or major hospitals with cardiology departments succeeded in adding one publication to the current list in the 25 years. Hacettepe and Cerrahpaşa medical faculties, GATA and Kartal Koşuyolu Research Hospital, as well as Turkey's Yüksek İhtisas Hospital, Erciyes and Süleyman Demirel university medical faculties merit special acknowledgment for having collectively generated just over half the quality research articles.

In the meantime, 19 papers (dating from 1999 to 2006) inclu-ded in our analysis 2 years previously failed to attain the added 10 citations and are, thus, not included herein. Conversely, 22 articles have succeeded to be newly selected for this evaluation.

Eight papers appearing as late as 2013 and 2014 succeeded in meeting the high threshold of this study. Şevket Balta and Sait Demirkol, along with the dermatologist İlknur Balta, produced three of the stated publications and thus, deserve tribute mention. M. Özkan, E. Hür, M.G. Kaya, N. Şen, and the current author were further actors of such a feat .

The exclusion of the period preceding 1992 precluded the inclusion of the following three scientists of the "old guard": the cardiovascular surgeons Aydın Aytaç and İlhan Paşaoğlu and the pediatric cardiologist late Teoman Onat, each of whom merits tribute mention in this study. The current list of scientists welcomes, in particular, Mehmet G. Kaya and Nihat Kalay from Erciyes U, Şevket Balta and Sait Demirkol from GATA, and Mehmet Kaplan of the S. Ersek center. Mehmet Özkan and Doğan Erdoğan have strengthened their previous scientific base as did Selma Yazıcı and Yusuf Tavil.

Cardiologists Birhan Yılmaz, Meral Kayıkçıoğlu, and Dursun Dursunoğlu and biochemist İlknur Tarkun merit special mention for their stimulating work.

Periodicals mediating successful research {#sec2-4}
-----------------------------------------

In particular, in this analysis, journals with relatively low impact factors, such as Coron Artery Dis, Angiology, or Eur J Cardiothorac Surg were also found to mediate in the success of 4--5 papers each. This implicates that well-designed and executed research may well be rewarded even when published in comparatively low-ranked journals.

Widening of the international gap in cardiologic research {#sec2-5}
---------------------------------------------------------

Asessments of higher quality research in (cardiovascular) medicine in Turkey ([@ref9]-[@ref11]) have indicated stagnation. Moving increasingly away from competency in scientific issues, lower support by the government to academic institutions, and functional reorientation of state hospitals primarily as out-patient clinics seem to have reduced the attraction of thorough research. Joining consensus statements or international trials with few contributed cases, which attain high number of citations, do not conceal the lack of "highly-cited" genuine articles.

Conclusion {#sec1-5}
==========

This evaluation of the "genuine" contribution of Turkey's institutions to global knowledge in cardiovascular medicine resulted in the identification of 147 articles with 50--392 citations, received at a median of 12 years. I detected substantial attenuation in publications of this quality after 2007. Only 38 medical faculties and hospitals generated these papers, representing disappointing performance of a majority of related institutions.

**Conflict of interest:** None declared.

**Peer-review:** Externally peer-reviewed.
